BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 25527608)

  • 1. Responses of GLP1-secreting L-cells to cytotoxicity resemble pancreatic β-cells but not α-cells.
    Vasu S; Moffett RC; McClenaghan NH; Flatt PR
    J Mol Endocrinol; 2015 Feb; 54(1):91-104. PubMed ID: 25527608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential molecular and cellular responses of GLP-1 secreting L-cells and pancreatic alpha cells to glucotoxicity and lipotoxicity.
    Vasu S; Moffett RC; McClenaghan NH; Flatt PR
    Exp Cell Res; 2015 Aug; 336(1):100-8. PubMed ID: 26027945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New Way for Beta Cell Neogenesis: Transdifferentiation from Alpha Cells Induced by Glucagon-Like Peptide 1.
    Zhang Z; Hu Y; Xu N; Zhou W; Yang L; Chen R; Yang R; Sun J; Chen H
    J Diabetes Res; 2019; 2019():2583047. PubMed ID: 31001561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-culture of clonal beta cells with GLP-1 and glucagon-secreting cell line impacts on beta cell insulin secretion, proliferation and susceptibility to cytotoxins.
    Green AD; Vasu S; Moffett RC; Flatt PR
    Biochimie; 2016 Jun; 125():119-25. PubMed ID: 27015674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. γ-Oryzanol protects pancreatic β-cells against endoplasmic reticulum stress in male mice.
    Kozuka C; Sunagawa S; Ueda R; Higa M; Tanaka H; Shimizu-Okabe C; Ishiuchi S; Takayama C; Matsushita M; Tsutsui M; Miyazaki J; Oyadomari S; Shimabukuro M; Masuzaki H
    Endocrinology; 2015 Apr; 156(4):1242-50. PubMed ID: 25594697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The orphan nuclear receptor small heterodimer partner negatively regulates pancreatic beta cell survival and hyperglycemia in multiple low-dose streptozotocin-induced type 1 diabetic mice.
    Noh JR; Hwang JH; Kim YH; Kim KS; Gang GT; Kim SW; Kim DK; Shong M; Lee IK; Choi HS; Lee CH
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1538-45. PubMed ID: 23680671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLP-1(28-36) improves β-cell mass and glucose disposal in streptozotocin-induced diabetic mice and activates cAMP/PKA/β-catenin signaling in β-cells in vitro.
    Shao W; Wang Z; Ip W; Chiang YT; Xiong X; Chai T; Xu C; Wang Q; Jin T
    Am J Physiol Endocrinol Metab; 2013 Jun; 304(12):E1263-72. PubMed ID: 23571712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
    Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
    Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF-I stimulates CCN5/WISP2 gene expression in pancreatic β-cells, which promotes cell proliferation and survival against streptozotocin.
    Chowdhury S; Wang X; Srikant CB; Li Q; Fu M; Gong YJ; Ning G; Liu JL
    Endocrinology; 2014 May; 155(5):1629-42. PubMed ID: 24552398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of glucagon-like peptide-1 (7-36) amide, isosteviol and 5-aminoimidazole-4-carboxamide 1-β-d-ribofuranoside on leucine-mediated α-cell dysfunction.
    Chen X; Hermansen K; Jeppesen PB
    Diabetes Obes Metab; 2012 Nov; 14(11):1020-31. PubMed ID: 22747908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DsAAV8-mediated expression of glucagon-like peptide-1 in pancreatic beta-cells ameliorates streptozotocin-induced diabetes.
    Riedel MJ; Gaddy DF; Asadi A; Robbins PD; Kieffer TJ
    Gene Ther; 2010 Feb; 17(2):171-80. PubMed ID: 19865180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NO-mediated cytotoxicity contributes to multiple low-dose streptozotocin-induced diabetes but not to NOD diabetes.
    Yasuda H; Jin Z; Nakayama M; Yamada K; Kishi M; Okumachi Y; Arai T; Moriyama H; Yokono K; Nagata M
    Diabetes Res Clin Pract; 2009 Feb; 83(2):200-7. PubMed ID: 19117633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of parenteral GLP-1 delivery by cell therapy in insulin-deficient streptozotocin diabetic mice.
    Vasu S; Moffett RC; McCluskey JT; Hamid MH; Irwin N; Flatt PR
    Gene Ther; 2013 Nov; 20(11):1077-84. PubMed ID: 23784442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
    Sternesjö J; Welsh N; Sandler S
    Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function.
    Granata R; Settanni F; Gallo D; Trovato L; Biancone L; Cantaluppi V; Nano R; Annunziata M; Campiglia P; Arnoletti E; Ghè C; Volante M; Papotti M; Muccioli G; Ghigo E
    Diabetes; 2008 Apr; 57(4):967-79. PubMed ID: 18162507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcholinesterase is associated with apoptosis in β cells and contributes to insulin-dependent diabetes mellitus pathogenesis.
    Zhang B; Yang L; Yu L; Lin B; Hou Y; Wu J; Huang Q; Han Y; Guo L; Ouyang Q; Zhang B; Lu L; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2012 Mar; 44(3):207-16. PubMed ID: 22236578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-3 deficiency protects pancreatic islet cells from cytokine-triggered apoptosis in vitro.
    Saksida T; Nikolic I; Vujicic M; Nilsson UJ; Leffler H; Lukic ML; Stojanovic I; Stosic-Grujicic S
    J Cell Physiol; 2013 Jul; 228(7):1568-76. PubMed ID: 23280610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced transcription of pancreatic peptide YY by 1α-hydroxyvitamin D3 administration in streptozotocin-induced diabetic mice.
    Ozeki J; Choi M; Endo-Umeda K; Sakurai K; Amano S; Makishima M
    Neuropeptides; 2013 Oct; 47(5):329-32. PubMed ID: 23899497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents.
    Eldor R; Yeffet A; Baum K; Doviner V; Amar D; Ben-Neriah Y; Christofori G; Peled A; Carel JC; Boitard C; Klein T; Serup P; Eizirik DL; Melloul D
    Proc Natl Acad Sci U S A; 2006 Mar; 103(13):5072-7. PubMed ID: 16551748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vildagliptin selectively ameliorates GLP-1, GLUT4, SREBP-1c mRNA levels and stimulates β-cell proliferation resulting in improved glucose homeostasis in rats with streptozotocin-induced diabetes.
    Akarte AS; Srinivasan BP; Gandhi S
    J Diabetes Complications; 2012; 26(4):266-74. PubMed ID: 22626875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.